News | November 14, 2024
AstraZeneca Pharma India posts Q2 PAT at Rs. 38.43 Cr
We are witnessing a steady and sustainable growth in the country as the Q2 revenue from operations increased by 31%
We are witnessing a steady and sustainable growth in the country as the Q2 revenue from operations increased by 31%
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
The company has posted net profit of Rs. 405.31 crores for the Financial Year ended March 31, 2024
Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024
Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023
Dabur India has reported total income of Rs. 3382.43 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated
